Chardan
Geulah Livshits is a Senior Research Analyst at Chardan, with a focus on biotech equity research since March 2018. Prior experience includes a role as a Postdoctoral Fellow at Memorial Sloan Kettering Cancer Center, where research centered on epigenetic regulators in pancreatic cancer utilizing advanced techniques such as CRISPR and RNAi. Geulah Livshits has also held positions as an intern at Chardan Capital Markets, LLC, and as a consultant for The Solution Lab, Inc., performing market analyses in the biotechnology sector. Academic credentials include a PhD in Molecular Cell Biology and Development from The Rockefeller University and a Summa Cum Laude BS in Biology from Brandeis University, supplemented by a certificate in the Fundamentals of the Bioscience Industry from Stony Brook University.
This person is not in the org chart
Chardan
Chardan is an independent global investment bank specializing in SPACs, healthcare, and disruptive innovation spanning all sectors. Our range of services include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, NASDAQ and the NYSE Arca, Inc. Disclaimer: Information posted on this Web site is believed to be reliable at the time of posting; Chardan Capital Markets, LLC and its affiliates cannot, however, guarantee the accuracy or completeness of such information or make any warranties with regard to the results to be obtained from its use. Information on this Web site is not intended to provide financial, legal, accounting or tax advice and should not be relied upon in that regard. Chardan Capital Markets, LLC and its affiliates are not responsible in any manner for direct, indirect, special or consequential damages howsoever caused, arising out of the use of this Web site or any of its content.